Division of Oncology, Bronx-Lebanon Hospital Center, Bronx, New York 10457, USA.
J Surg Oncol. 2010 Sep 1;102(3):282-6. doi: 10.1002/jso.21590.
We present our experience in the era of HAART with 5,112 patients having HIV infection or AIDS, treated between 2002 and 2006 in our hospital, 182 of whom had malignancies (3.56%). We compared our findings to those from a similar cohort of patients studied 10 years earlier.
The charts were reviewed and data was electronically collected as in our 1993-1998 study. Similar statistical analyses were performed in both studies and the results were compared.
For the current study the average patient age increased by 9 years. A decrease in AIDS-defining cancers (ADC), from 63.6% to 37.3% and a higher incidence of non-AIDS-defining cancers (NADC), 62.7 as opposed to 37.9% was found. No decrease in the incidence of non-Hodgkin's B cell lymphoma (NHL) was noted. There was an increase in the number of opportunistic infections notably hepatitis C virus (HCV) and hepatitis B virus (HBV).
HIV/AIDS patients on HAART are older, have lower rates of AIDS related Kaposi's sarcoma and a higher incidence of NADCs than did patients in the early HAART era. No decrease in the proportion of NHL was observed.
我们展示了在高效抗逆转录病毒治疗(HAART)时代的经验,共有 5112 例 HIV 感染者或 AIDS 患者在我们医院接受治疗,其中 182 例(3.56%)患有恶性肿瘤。我们将我们的发现与 10 年前类似患者队列的研究结果进行了比较。
回顾病历并电子收集数据,与我们 1993-1998 年的研究相同。在两项研究中均进行了类似的统计分析,并比较了结果。
对于当前的研究,患者的平均年龄增加了 9 岁。艾滋病定义性癌症(ADC)的发病率从 63.6%下降至 37.3%,而非艾滋病定义性癌症(NADC)的发病率从 37.9%上升至 62.7%。非霍奇金 B 细胞淋巴瘤(NHL)的发病率没有下降。机会性感染的数量增加,特别是丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)。
接受 HAART 的 HIV/AIDS 患者比早期 HAART 时代的患者年龄更大,艾滋病相关卡波西肉瘤的发病率更低,NADCs 的发病率更高。NHL 的比例没有下降。